Accelerate Diagnostics reports Q2 2018 financial results
Aug 06, 2018
Revenue up 142 Percent, Global install base up 25 Percent
TUCSON, Ariz., Aug. 6, 2018 /PRNewswire/ — Accelerate Diagnostics, Inc. today announced financial results for the quarter ending June 30, 2018. The company posted revenue of $1.7 million, up 142% from the prior year quarter, and reported a record number of new agreements signed in the quarter bringing the global total to 430 instruments. Contracts for customer evaluations total 312 instruments while commercial placements grew to 118 across the U.S., European, and Middle East regions.
“We’re excited to report a record number of new customer agreements this quarter,” said Lawrence Mehren, President and CEO. “While not yet fully translated into revenue, this sales momentum, strong customer advocacy, and upcoming clinical outcome data are quite encouraging.”
Read the full announcement
- Clinicians at Moffitt Cancer Center make a difference for patients by optimizing antibiotic therapy earlier
Mar 06, 2020